Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | |
---|---|---|---|---|
1 | 2 | |||
Asthenia | 13% | 14% | x | x |
Abdominal pain | 9% | 11% | x | x |
Headache | 9% | 10% | x | x |
Nausea | 5% | 8% | x | x |
Flatulence | 4% | 4% | x | x |
Diarrhoea | 3% | 4% | x | x |
Dyspepsia | 3% | 2% | x | x |
Connective tissue disorder | postmarketing | x | x | |
Fanconi syndrome | postmarketing | x | x | |
Fracture | postmarketing | x | ||
Gastrointestinal disorder | postmarketing | x | x | |
Myopathy | postmarketing | x | x | |
Osteomalacia | postmarketing | x | x | |
Pancreatitis | postmarketing | x | x | |
Renal failure | postmarketing | x | x | |
Urinary tract disorder | postmarketing | x | x | |
Hypophosphataemia | postmarketing | x | x | |
Bone pain | postmarketing | x | ||
Malnutrition | postmarketing | x | x | |
Rash | x | x | ||
Hepatitis | x | x | ||
Pruritus | x | x | ||
Vomiting | x | x | ||
Creatinine increased | x | x | ||
Kidney function abnormal | x | x | ||
Nephrotoxicity | x | x | ||
Serum creatinine increased | x | x | ||
Phosphorus low | x | x | ||
Renal impairment | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |